Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Chronic Irritability in Neurologically Impaired Children
NCT01675960Phase 2Terminated
- Sponsor
- Gillette Children's Specialty Healthcare
- Start
- Apr 2012
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin, sponsored by Gillette Children's Specialty Healthcare. Started Apr 2012; status: terminated.
02
Drugs
gabapentin
Beyond the preview
Go deeper on NCT01675960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675960.